Quiz|Articles|December 6, 2025
Dermatology Times Spot Test: December 7, 2025
Author(s)Marie Bosslett, Assistant Editor
Listen
0:00 / 0:00
Key Takeaways
- A network meta-analysis evaluates the efficacy and safety of various chronic hand eczema therapies, aiding clinical decision-making.
- Personalized treatment plans are emphasized, considering both effectiveness and potential side effects of each therapy.
Put your dermatology expertise to the test with Dermatology Times’ interactive quiz series!
Advertisement
Dermatology Times presents: Spot Test!
Each week, dive into a series of thought-provoking questions designed to test your understanding of essential topics, trends, and breakthroughs in dermatology. This week, we'll focus on insights from a
Do you have a set of quiz questions to share? Contact editor Marie Bosslett at
Approximately what percentage of the global population is affected by CHE?
Which treatment was ranked most efficacious across all networks and sensitivity analyses?
Which clinical implication is highlighted by the superiority of delgocitinib over alitretinoin?
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Related Content
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Clascoterone 5% Delivers Strong Phase 3 Hair-Growth Results
2
Nearly Half of Female Psoriasis Patients Report IPV, Study Finds
3
New Analysis Finds Radiofrequency Microneedling Superior for Rosacea Erythema and Patient Satisfaction
4
Experts See Promise in AI for Atopic Dermatitis Care
5
